(redirected from Pulmonary diseases)
Also found in: Medical, Encyclopedia.
Related to Pulmonary diseases: COPD


 (po͝ol′mə-nŏl′ə-jē, pŭl′-)
The branch of medicine that deals with diseases of the respiratory system.

[Latin pulmō, pulmōn-, lung; see pulmonary + -logy.]

pul′mo·nol′o·gist n.


(Medicine) the branch of medical science concerned with the lungs and respiratory system and their diseases
ˌpulmonˈologist n


n neumología, rama de la medicina que se ocupa de los pulmones y sus enfermedades
References in periodicals archive ?
Main credit risks include National Jewish's reliance on charitable contributions and other non-operating revenue, as well as susceptibility to federal cutbacks due to its narrow program breadth largely focused on pulmonary diseases.
announced today a collaboration and license agreement to develop multiple non-viral gene-based products to treat pulmonary diseases utilizing MaxCyte's proprietary cell loading system.
is in the business of developing, producing and marketing respiratory care devices designed to improve the efficiency of oxygen delivery systems for home health care and hospital treatment of patients suffering from pulmonary diseases.
In addition, Pulmatrix is pursuing opportunities in major pulmonary diseases through collaborations, including PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD).
SeeNews) - Jul 1, 2014 - Belgian biotechnology firmA GalapagosA (EBR:GLPG) said Tuesday it would start a Phase I clinical trial with the GLPG1690 molecule aimed at treating pulmonary diseases.
As the air becomes more contaminated, incidence of asthma and chronic obstructive pulmonary diseases also increases.
The former miner believes more must be done not just for ex-pitmen with coal-dust afflictions, but also for those with pulmonary diseases and breathing difficulties.
Pulmonary diseases often induce panic attacks, which could contribute to thoughts of killing oneself, comment internist Bruce L.
The study suggests ah interaction of genetic background with environmental exposure, and further suggests that intermediate responses are important in the development and progression of chronic pulmonary diseases such as coal workers' pneumoconiosis.
We've successfully used nebulizers for many patients with pulmonary diseases for years, and I'm excited that BROVANA received FDA approval, making it the first nebulized long-acting bronchodilator for use in COPD.
Specifically, they sought to evaluate whether the risk factors associated with cardiovascular and pulmonary diseases and lung cancer occurred differently among the exposed and unexposed women, possibly indicating that adverse health effects attributed to ETS exposure might instead be caused by other factors shared by the women married to smokers.